Additional file 2 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

  • Maryam Soleimani Dodaran (Contributor)
  • Simone Borgoni (Creator)
  • Emre Sofyall (Contributor)
  • Pernette J. Verschure (Contributor)
  • Stefan Wiemann (Creator)
  • Perry Moerland (Creator)
  • Antoine van Kampen (Contributor)
  • Emre Sofyalı (Creator)

Dataset

Description

Additional file 2. Molecular subtypes. Overview of the molecular subtype frequency as determined by immunohistochemistry of ER and HER2 and as predicted by the SCMOD2 model (R package genefu) using TGCA BRCA primary tumour gene expression data. Subtypes...
Date made available2020
PublisherFigshare

Cite this